SEGMENT AND GEOGRAPHIC INFORMATION (Tables)
|
6 Months Ended |
Jun. 30, 2024 |
| Segment Reporting [Abstract] |
|
| Schedule of Net Sales and Profit by Segments |
Net sales and profit by each reportable segment for the three and six months ended June 30, 2024 and 2023 are as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | Dollars in thousands | 2024 | | 2023 | | 2024 | | 2023 | | Segment Net Sales | | | | | | | | | Codman Specialty Surgical | $ | 301,761 | | | $ | 271,030 | | | $ | 558,195 | | | $ | 519,166 | | Tissue Technologies | 116,414 | | | 110,237 | | | 228,852 | | | 242,947 | | | Total revenues | $ | 418,175 | | | $ | 381,267 | | | $ | 787,047 | | | $ | 762,113 | | | Segment Profit | | | | | | | | | Codman Specialty Surgical | $ | 164,141 | | | $ | 116,341 | | | $ | 267,633 | | | $ | 227,274 | | Tissue Technologies | 37,187 | | | 8,062 | | | 67,853 | | 60,343 | | | Segment profit | 201,328 | | | 124,403 | | | 335,486 | | | 287,617 | | | Amortization | (3,707) | | (3,026) | | (13,814) | | | (6,134) | | Corporate and other | (200,650) | | | (108,873) | | | (320,737) | | (232,597) | | Operating income | $ | (3,029) | | | $ | 12,504 | | | $ | 935 | | | $ | 48,886 | |
Total revenue by major geographic area consisted of the following: | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | Dollars in thousands | 2024 | | 2023 | | 2024 | | 2023 | | United States | $ | 310,225 | | | $ | 276,782 | | | $ | 566,454 | | | $ | 547,784 | | | Europe | 40,689 | | | 37,452 | | | 82,285 | | | 78,516 | | | Asia Pacific | 45,951 | | | 47,706 | | | 95,496 | | | 98,179 | | | Rest of World | 21,310 | | | 19,327 | | | 42,812 | | | 37,634 | | | Total Revenues | $ | 418,175 | | | $ | 381,267 | | | $ | 787,047 | | | $ | 762,113 | |
|
| Schedule of Geographic Revenue by Area |
Net sales and profit by each reportable segment for the three and six months ended June 30, 2024 and 2023 are as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | Dollars in thousands | 2024 | | 2023 | | 2024 | | 2023 | | Segment Net Sales | | | | | | | | | Codman Specialty Surgical | $ | 301,761 | | | $ | 271,030 | | | $ | 558,195 | | | $ | 519,166 | | Tissue Technologies | 116,414 | | | 110,237 | | | 228,852 | | | 242,947 | | | Total revenues | $ | 418,175 | | | $ | 381,267 | | | $ | 787,047 | | | $ | 762,113 | | | Segment Profit | | | | | | | | | Codman Specialty Surgical | $ | 164,141 | | | $ | 116,341 | | | $ | 267,633 | | | $ | 227,274 | | Tissue Technologies | 37,187 | | | 8,062 | | | 67,853 | | 60,343 | | | Segment profit | 201,328 | | | 124,403 | | | 335,486 | | | 287,617 | | | Amortization | (3,707) | | (3,026) | | (13,814) | | | (6,134) | | Corporate and other | (200,650) | | | (108,873) | | | (320,737) | | (232,597) | | Operating income | $ | (3,029) | | | $ | 12,504 | | | $ | 935 | | | $ | 48,886 | |
Total revenue by major geographic area consisted of the following: | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | Dollars in thousands | 2024 | | 2023 | | 2024 | | 2023 | | United States | $ | 310,225 | | | $ | 276,782 | | | $ | 566,454 | | | $ | 547,784 | | | Europe | 40,689 | | | 37,452 | | | 82,285 | | | 78,516 | | | Asia Pacific | 45,951 | | | 47,706 | | | 95,496 | | | 98,179 | | | Rest of World | 21,310 | | | 19,327 | | | 42,812 | | | 37,634 | | | Total Revenues | $ | 418,175 | | | $ | 381,267 | | | $ | 787,047 | | | $ | 762,113 | |
|